- Home
- INVZ vs INMB Comparison
INVZ vs INMB Comparison
Compare INVZ & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVZ
- INMB
- Stock Information
- Founded
- INVZ 2016
- INMB 2015
- Country
- INVZ Israel
- INMB United States
- Employees
- INVZ N/A
- INMB N/A
- Industry
- INVZ Auto Parts:O.E.M.
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- INVZ Consumer Discretionary
- INMB Health Care
- Exchange
- INVZ Nasdaq
- INMB Nasdaq
- Market Cap
- INVZ 186.3M
- INMB 176.5M
- IPO Year
- INVZ N/A
- INMB 2019
- Fundamental
- Price
- INVZ $1.50
- INMB $2.36
- Analyst Decision
- INVZ Strong Buy
- INMB Buy
- Analyst Count
- INVZ 5
- INMB 4
- Target Price
- INVZ $3.38
- INMB $9.53
- AVG Volume (30 Days)
- INVZ 9.2M
- INMB 6.3M
- Earning Date
- INVZ 08-06-2025
- INMB 07-31-2025
- Dividend Yield
- INVZ N/A
- INMB N/A
- EPS Growth
- INVZ N/A
- INMB N/A
- EPS
- INVZ N/A
- INMB N/A
- Revenue
- INVZ $34,601,000.00
- INMB $50,000.00
- Revenue This Year
- INVZ $137.25
- INMB $82.14
- Revenue Next Year
- INVZ $128.53
- INMB $28,750.98
- P/E Ratio
- INVZ N/A
- INMB N/A
- Revenue Growth
- INVZ 28.52
- INMB N/A
- 52 Week Low
- INVZ $0.45
- INMB $1.89
- 52 Week High
- INVZ $3.14
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- INVZ 66.59
- INMB 24.85
- Support Level
- INVZ $1.20
- INMB $1.89
- Resistance Level
- INVZ $1.58
- INMB $11.64
- Average True Range (ATR)
- INVZ 0.17
- INMB 1.18
- MACD
- INVZ 0.03
- INMB -0.57
- Stochastic Oscillator
- INVZ 80.00
- INMB 4.82
About INVZ Innoviz Technologies Ltd. Ordinary shares
Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.